Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry.

scientific article

Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CHROMA.2007.06.063
P698PubMed publication ID17640657

P2093author name stringMei Han
Boxu Yan
Susan Elliott
John Valliere-Douglass
Alain Balland
Danielle Pace
Lowell Brady
Sean Steen
Weichun Wang
Yihong Han
Zac Yates
Dean Pettit
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
P304page(s)153-161
P577publication date2007-07-05
P1433published inJournal of ChromatographyQ902558
P1476titleAnalysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry.
P478volume1164

Reverse relations

cites work (P2860)
Q50860057A High-Throughput Bioluminescent Assay to Monitor the Deamidation of Asparagine and Isomerization of Aspartate Residues in Therapeutic Proteins and Antibodies.
Q34223967A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization
Q36588710A novel approach for the simultaneous quantification of a therapeutic monoclonal antibody in serum produced from two distinct host cell lines
Q39324555Capillary electrophoresis-mass spectrometry methods for tryptic peptide mapping of therapeutic antibodies
Q38155231Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratory
Q35624029Characterization of the basic charge variants of a human IgG1: effect of copper concentration in cell culture media
Q94503762Computational Studies on the Mechanisms of Nonenzymatic Intramolecular Cyclization of the Glutamine Residues Located at N-Termini Catalyzed by Inorganic Phosphate Species
Q38665164Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.
Q41955520Desulfurization of cysteine-containing peptides resulting from sample preparation for protein characterization by mass spectrometry
Q37364361Developability studies before initiation of process development: improving manufacturability of monoclonal antibodies
Q30398538FTIR markers of methionine oxidation for early detection of oxidized protein therapeutics
Q37467563Human IgG1 hinge fragmentation as the result of H2O2-mediated radical cleavage
Q88673235Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics
Q44517032Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF.
Q51791478Molecular mass analysis of antibodies by on-line SEC-MS.
Q28821982Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies
Q30278544Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis
Q38246996Post-translational structural modifications of immunoglobulin G and their effect on biological activity
Q37122550RPLC of intact proteins using sub-0.5 μm particles and commercial instrumentation
Q42929516Rapid and refined separation of human IgG2 disulfide isomers using superficially porous particles
Q37689616Stability of protein pharmaceuticals: an update
Q40115327The Effect of N-Terminal Cyclization on the Function of the HIV Entry Inhibitor 5P12-RANTES.
Q42875883The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms
Q38668408The use of proteases complementary to trypsin to probe isoforms and modifications.

Search more.